Skip to content
Screener

Ginkgo Bioworks DNA Food and nutrition — Concentration risk

Other product segments

Government and defense
45%+114%
Agriculture
20%-13.0%
Pharmaceutical and biotechnology
20%—
Consumer and technology
6%+200%
Industrial and environment
2%-50.0%

Similar metrics at other companies

Centerspace logo
CSRFee Income — Concentration risk
1.4%-0.2pp
Centerspace logo
CSRRental Income — Concentration risk
98.6%+0.2pp
Maximus logo
MMSTechnology Solutions — Concentration risk
5.3%-0.6pp
Blue Owl Capital logo
OBDCInternational — Concentration risk
7.1%+0.9pp
Blue Owl Capital logo
OBDCMidwest — Concentration risk
20.5%-1.2pp
Blue Owl Capital logo
OBDCNortheast — Concentration risk
21.7%+3.8pp

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.0%
Enterprise value$752.73M-14.6%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%—
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity1×+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.

The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054298
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Government and defense45%21%41%19%
Pharmaceutical and biotechnology20442938
Agriculture20231632
Food and nutrition7675
Consumer and technology6231
Industrial and environment2445
Total revenue100%100%100%100%

Item 1. Financial Statements (Unaudited)

FAQ

What is Ginkgo Bioworks's food and nutrition — concentration risk?
Ginkgo Bioworks (DNA) reported food and nutrition — concentration risk of 7% in Q2 2026.
How has Ginkgo Bioworks's food and nutrition — concentration risk changed year-over-year?
Ginkgo Bioworks's food and nutrition — concentration risk increased by 16.7% year-over-year, from 6% to 7%.
What does food and nutrition — concentration risk mean?
This metric measures the proportion of total segment revenue derived from a limited number of key customers or specific contracts within the food and nutrition business unit. A high concentration indicates significant dependency on a small group of partners, which increases vulnerability to contract terminations or shifts in client-specific demand. Monitoring this risk helps investors assess the stability and diversification of the revenue stream within this specialized service vertical.

Ask your AI about Ginkgo Bioworks's food and nutrition — concentration risk.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude